Clinical Trial Update: Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of PJ009 for Short Bowel Syndrome requiring parenteral nutrition is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• PJ009

Snippet

Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. | Conditions: Short Bowel Syndrome | Phase 3 | Status: RECRUITING